Ingredients

FDA updates and actions on COVID-19

01-Apr-2020 By Jenni Spinner

The federal agency has announced a slew of legislation, advisory statements and other items impacting the US in the face of the pandemic.

MedPharm donates hand sanitizer to combat COVID-19

31-Mar-2020 By Jenni Spinner

The company has shifted production to manufacture sanitizer, intended to protect healthcare providers and other essential workers from coronavirus.

SPI Pharma expands line of mannitol products

30-Mar-2020 By Jenni Spinner

The company has added four mannitols to its Mannogem line, designed for optimal compressibility, binding, disintegration and particle size ranges.

India invests to boost domestic API manufacture

26-Mar-2020 By Ben Hargreaves

Following API constraints due to the coronavirus, the Indian government takes measures to bolster domestic capabilities.

FDA lifts import alert on Ipca Labs for chloroquine supply

24-Mar-2020 By Ben Hargreaves

In order to boost the supply of chloroquine, the US FDA has allowed Ipca to supply APIs and finished product to the country.

Indian export group says European industry ‘panicking’ over APIs

05-Mar-2020 By Ben Hargreaves

After the Indian government moved to limit the export of APIs, an Indian export association says fear is spreading amongst European businesses over supply.

Indian government shuts down export of certain APIs due to coronavirus

03-Mar-2020 By Ben Hargreaves

With the supply of certain APIs limited by the spread of the virus, Indian government orders restrictions on the export of ingredients and formulations.

‘You get what you pay for’ on API quality

19-Feb-2020 By Ben Hargreaves

As C2 Pharma works to expand its API portfolio, its CEO states that there is ‘no short game’ on API quality.

Sun Pharma blames 'speculative buying' on coronavirus-related price hikes

17-Feb-2020 By Nick Taylor

Sun Pharma argues rising ingredient and finished product prices are unjustified, blames ‘speculative buying’ for trend.

Pfizer's CDMO unit drives growth at hospital business

03-Feb-2020 By Nick Taylor

Pfizer attributes performance of contract manufacturing unit as driver of growth at hospital business.

Could the coronavirus impact supply of APIs?

29-Jan-2020 By Ben Hargreaves

First quarter supplies of APIs are expected to be affected by the recent outbreak of coronavirus, according to survey.

GSK develops new chemical-class antibiotic to fight AMR

29-Oct-2019 By Vassia Barba

GSK announces it initiated Phase III trials for gepotidacin, the first in a new class of antibiotics, as an potential treatment for urinary tract infection.

LBB to supply Meggle’s excipients in the US market

05-Sep-2019 By Vassia Barba

LBB takes on the marketing and distribution of Meggle’s lactose-based excipients for direct compression and inhalation in the US market.

Pharmaceutical excipients market to hit $9.8bn by 2025

28-Aug-2019 By Vassia Barba

Bolstered by manufacturing advancements, the global revenues of the pharmaceutical excipients market are expected to grow at a CAGR of 5.8% in the coming years.